nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—SLC22A7—Fluorouracil—skin cancer	0.0753	0.102	CbGbCtD
Theophylline—CYP1A2—Imiquimod—skin cancer	0.0663	0.0897	CbGbCtD
Theophylline—CYP1B1—Docetaxel—skin cancer	0.0635	0.086	CbGbCtD
Theophylline—CYP1A1—Dacarbazine—skin cancer	0.0623	0.0843	CbGbCtD
Theophylline—CYP2C8—Vismodegib—skin cancer	0.0593	0.0803	CbGbCtD
Theophylline—SLC22A7—Docetaxel—skin cancer	0.0575	0.0778	CbGbCtD
Theophylline—CYP2E1—Dacarbazine—skin cancer	0.0481	0.0651	CbGbCtD
Theophylline—CYP2C9—Vismodegib—skin cancer	0.0414	0.056	CbGbCtD
Theophylline—CYP1A2—Vemurafenib—skin cancer	0.0363	0.0491	CbGbCtD
Theophylline—CYP3A4—Temozolomide—skin cancer	0.0347	0.047	CbGbCtD
Theophylline—CYP3A4—Imiquimod—skin cancer	0.0347	0.047	CbGbCtD
Theophylline—CYP2D6—Vemurafenib—skin cancer	0.0299	0.0405	CbGbCtD
Theophylline—CYP1A2—Dacarbazine—skin cancer	0.0278	0.0377	CbGbCtD
Theophylline—CYP3A4—Vismodegib—skin cancer	0.0241	0.0326	CbGbCtD
Theophylline—CYP2C8—Fluorouracil—skin cancer	0.0211	0.0285	CbGbCtD
Theophylline—CYP3A4—Vemurafenib—skin cancer	0.019	0.0257	CbGbCtD
Theophylline—CYP1A2—Fluorouracil—skin cancer	0.0163	0.0221	CbGbCtD
Theophylline—CYP2C9—Fluorouracil—skin cancer	0.0147	0.0199	CbGbCtD
Theophylline—PDE5A—penis—skin cancer	0.00745	0.0896	CbGeAlD
Theophylline—PDE3A—penis—skin cancer	0.00724	0.0871	CbGeAlD
Theophylline—CYP3A4—Docetaxel—skin cancer	0.00653	0.00883	CbGbCtD
Theophylline—Status epilepticus—Temozolomide—skin cancer	0.0043	0.043	CcSEcCtD
Theophylline—ADORA1—nerve—skin cancer	0.00324	0.039	CbGeAlD
Theophylline—PDE5A—endothelium—skin cancer	0.00291	0.035	CbGeAlD
Theophylline—PDE5A—blood vessel—skin cancer	0.00268	0.0323	CbGeAlD
Theophylline—HDAC2—hair follicle—skin cancer	0.00268	0.0323	CbGeAlD
Theophylline—Supraventricular tachycardia—Imiquimod—skin cancer	0.00258	0.0258	CcSEcCtD
Theophylline—ADORA2B—nipple—skin cancer	0.00256	0.0308	CbGeAlD
Theophylline—PDE3B—connective tissue—skin cancer	0.00219	0.0264	CbGeAlD
Theophylline—Abdominal pain upper—Vismodegib—skin cancer	0.00213	0.0213	CcSEcCtD
Theophylline—Hypokalaemia—Vismodegib—skin cancer	0.00212	0.0212	CcSEcCtD
Theophylline—Gastrooesophageal reflux disease—Imiquimod—skin cancer	0.00187	0.0187	CcSEcCtD
Theophylline—HDAC2—neck—skin cancer	0.0018	0.0216	CbGeAlD
Theophylline—CYP1B1—hair follicle—skin cancer	0.00172	0.0207	CbGeAlD
Theophylline—CYP1A1—skin epidermis—skin cancer	0.0017	0.0205	CbGeAlD
Theophylline—Sinus tachycardia—Docetaxel—skin cancer	0.00167	0.0167	CcSEcCtD
Theophylline—ADA—connective tissue—skin cancer	0.00166	0.02	CbGeAlD
Theophylline—Atrial fibrillation—Vemurafenib—skin cancer	0.00152	0.0152	CcSEcCtD
Theophylline—ADORA2B—mammalian vulva—skin cancer	0.0015	0.018	CbGeAlD
Theophylline—Alopecia—Vismodegib—skin cancer	0.00142	0.0142	CcSEcCtD
Theophylline—PDE5A—connective tissue—skin cancer	0.00138	0.0166	CbGeAlD
Theophylline—Extravasation—Bleomycin—skin cancer	0.00138	0.0138	CcSEcCtD
Theophylline—ADA—mammalian vulva—skin cancer	0.00137	0.0165	CbGeAlD
Theophylline—PDE4B—nipple—skin cancer	0.00136	0.0164	CbGeAlD
Theophylline—PDE5A—epithelium—skin cancer	0.00131	0.0157	CbGeAlD
Theophylline—Dermatitis exfoliative—Imiquimod—skin cancer	0.0013	0.013	CcSEcCtD
Theophylline—Atrial fibrillation—Imiquimod—skin cancer	0.00129	0.0129	CcSEcCtD
Theophylline—HDAC2—connective tissue—skin cancer	0.00129	0.0155	CbGeAlD
Theophylline—Extravasation—Dactinomycin—skin cancer	0.00128	0.0128	CcSEcCtD
Theophylline—PDE4C—head—skin cancer	0.00122	0.0147	CbGeAlD
Theophylline—HDAC2—epithelium—skin cancer	0.00122	0.0147	CbGeAlD
Theophylline—ADA—lymphoid tissue—skin cancer	0.00121	0.0146	CbGeAlD
Theophylline—ADA—female reproductive system—skin cancer	0.00117	0.0141	CbGeAlD
Theophylline—Irritability—Imiquimod—skin cancer	0.00117	0.0117	CcSEcCtD
Theophylline—Urinary retention—Imiquimod—skin cancer	0.00117	0.0117	CcSEcCtD
Theophylline—HDAC2—skin of body—skin cancer	0.00116	0.014	CbGeAlD
Theophylline—Nervous system disorder—Vismodegib—skin cancer	0.00112	0.0112	CcSEcCtD
Theophylline—ADORA2A—lymphoid tissue—skin cancer	0.00111	0.0133	CbGeAlD
Theophylline—ADORA2B—head—skin cancer	0.00107	0.0129	CbGeAlD
Theophylline—Extravasation—Fluorouracil—skin cancer	0.00107	0.0107	CcSEcCtD
Theophylline—ADORA2A—female reproductive system—skin cancer	0.00107	0.0128	CbGeAlD
Theophylline—Supraventricular tachycardia—Docetaxel—skin cancer	0.00103	0.0103	CcSEcCtD
Theophylline—Phlebitis—Bleomycin—skin cancer	0.00101	0.0101	CcSEcCtD
Theophylline—Decreased appetite—Vismodegib—skin cancer	0.000994	0.00995	CcSEcCtD
Theophylline—ADA—head—skin cancer	0.000979	0.0118	CbGeAlD
Theophylline—Disorientation—Bleomycin—skin cancer	0.000974	0.00974	CcSEcCtD
Theophylline—PDE5A—female reproductive system—skin cancer	0.000971	0.0117	CbGeAlD
Theophylline—PDE3A—female reproductive system—skin cancer	0.000944	0.0114	CbGeAlD
Theophylline—Phlebitis—Dactinomycin—skin cancer	0.000943	0.00943	CcSEcCtD
Theophylline—HDAC2—lymphoid tissue—skin cancer	0.000943	0.0113	CbGeAlD
Theophylline—Gastrointestinal pain—Vismodegib—skin cancer	0.000935	0.00936	CcSEcCtD
Theophylline—Dermatitis contact—Fluorouracil—skin cancer	0.000922	0.00922	CcSEcCtD
Theophylline—ADORA1—female reproductive system—skin cancer	0.00092	0.0111	CbGeAlD
Theophylline—HDAC2—female reproductive system—skin cancer	0.000909	0.0109	CbGeAlD
Theophylline—PDE3B—lymph node—skin cancer	0.000904	0.0109	CbGeAlD
Theophylline—Abdominal pain—Vismodegib—skin cancer	0.000904	0.00905	CcSEcCtD
Theophylline—ADORA2A—head—skin cancer	0.000891	0.0107	CbGeAlD
Theophylline—Alopecia—Vemurafenib—skin cancer	0.000879	0.00879	CcSEcCtD
Theophylline—Coma—Fluorouracil—skin cancer	0.000852	0.00853	CcSEcCtD
Theophylline—CYP1A2—nipple—skin cancer	0.000836	0.0101	CbGeAlD
Theophylline—CYP1B1—connective tissue—skin cancer	0.000827	0.00995	CbGeAlD
Theophylline—CYP1A1—nipple—skin cancer	0.000825	0.00992	CbGeAlD
Theophylline—PDE5A—head—skin cancer	0.000811	0.00976	CbGeAlD
Theophylline—Pruritus—Vismodegib—skin cancer	0.000809	0.0081	CcSEcCtD
Theophylline—PDE4B—mammalian vulva—skin cancer	0.000795	0.00956	CbGeAlD
Theophylline—Flushing—Imiquimod—skin cancer	0.000787	0.00788	CcSEcCtD
Theophylline—Diarrhoea—Vismodegib—skin cancer	0.000783	0.00783	CcSEcCtD
Theophylline—Dermatitis exfoliative—Temozolomide—skin cancer	0.000779	0.00779	CcSEcCtD
Theophylline—Extravasation—Docetaxel—skin cancer	0.000771	0.00772	CcSEcCtD
Theophylline—ADORA1—head—skin cancer	0.000769	0.00925	CbGeAlD
Theophylline—HDAC2—head—skin cancer	0.000759	0.00914	CbGeAlD
Theophylline—Arrhythmia—Imiquimod—skin cancer	0.000758	0.00758	CcSEcCtD
Theophylline—Disorientation—Fluorouracil—skin cancer	0.000757	0.00757	CcSEcCtD
Theophylline—PDE4D—lymph node—skin cancer	0.000755	0.00908	CbGeAlD
Theophylline—Alopecia—Imiquimod—skin cancer	0.000749	0.0075	CcSEcCtD
Theophylline—CYP1B1—skin of body—skin cancer	0.000747	0.00899	CbGeAlD
Theophylline—Vomiting—Vismodegib—skin cancer	0.000727	0.00728	CcSEcCtD
Theophylline—Rash—Vismodegib—skin cancer	0.000721	0.00722	CcSEcCtD
Theophylline—Dermatitis—Vismodegib—skin cancer	0.00072	0.00721	CcSEcCtD
Theophylline—Anaphylactic shock—Vemurafenib—skin cancer	0.000707	0.00707	CcSEcCtD
Theophylline—PDE4B—lymphoid tissue—skin cancer	0.000706	0.00849	CbGeAlD
Theophylline—Infection—Vemurafenib—skin cancer	0.000702	0.00702	CcSEcCtD
Theophylline—Nervous system disorder—Vemurafenib—skin cancer	0.000693	0.00693	CcSEcCtD
Theophylline—ADA—lymph node—skin cancer	0.000685	0.00825	CbGeAlD
Theophylline—PDE4B—female reproductive system—skin cancer	0.000681	0.00819	CbGeAlD
Theophylline—Nausea—Vismodegib—skin cancer	0.000679	0.0068	CcSEcCtD
Theophylline—Agitation—Imiquimod—skin cancer	0.000679	0.00679	CcSEcCtD
Theophylline—Hypokalaemia—Temozolomide—skin cancer	0.000669	0.00669	CcSEcCtD
Theophylline—PDE4A—lymph node—skin cancer	0.000668	0.00804	CbGeAlD
Theophylline—Hypotension—Vemurafenib—skin cancer	0.00066	0.00661	CcSEcCtD
Theophylline—Palpitations—Imiquimod—skin cancer	0.000652	0.00653	CcSEcCtD
Theophylline—Irritability—Fluorouracil—skin cancer	0.000646	0.00646	CcSEcCtD
Theophylline—Haematuria—Bleomycin—skin cancer	0.00064	0.0064	CcSEcCtD
Theophylline—Convulsion—Imiquimod—skin cancer	0.00064	0.0064	CcSEcCtD
Theophylline—Anxiety—Imiquimod—skin cancer	0.000626	0.00627	CcSEcCtD
Theophylline—Decreased appetite—Vemurafenib—skin cancer	0.000614	0.00615	CcSEcCtD
Theophylline—CYP1B1—lymphoid tissue—skin cancer	0.000605	0.00728	CbGeAlD
Theophylline—Infection—Imiquimod—skin cancer	0.000599	0.00599	CcSEcCtD
Theophylline—Shock—Imiquimod—skin cancer	0.000593	0.00593	CcSEcCtD
Theophylline—Nervous system disorder—Imiquimod—skin cancer	0.000591	0.00591	CcSEcCtD
Theophylline—Tachycardia—Imiquimod—skin cancer	0.000588	0.00588	CcSEcCtD
Theophylline—CYP1B1—female reproductive system—skin cancer	0.000583	0.00702	CbGeAlD
Theophylline—Anorexia—Imiquimod—skin cancer	0.000574	0.00575	CcSEcCtD
Theophylline—Hyperglycaemia—Temozolomide—skin cancer	0.000573	0.00573	CcSEcCtD
Theophylline—PDE4B—head—skin cancer	0.000569	0.00684	CbGeAlD
Theophylline—PDE5A—lymph node—skin cancer	0.000568	0.00683	CbGeAlD
Theophylline—Phlebitis—Docetaxel—skin cancer	0.000567	0.00567	CcSEcCtD
Theophylline—Flushing—Bleomycin—skin cancer	0.000559	0.0056	CcSEcCtD
Theophylline—Body temperature increased—Vemurafenib—skin cancer	0.000559	0.00559	CcSEcCtD
Theophylline—CYP1A1—epithelium—skin cancer	0.000555	0.00668	CbGeAlD
Theophylline—PDE3A—lymph node—skin cancer	0.000552	0.00665	CbGeAlD
Theophylline—Insomnia—Imiquimod—skin cancer	0.000545	0.00545	CcSEcCtD
Theophylline—ADORA1—lymph node—skin cancer	0.000538	0.00648	CbGeAlD
Theophylline—Alopecia—Bleomycin—skin cancer	0.000532	0.00533	CcSEcCtD
Theophylline—HDAC2—lymph node—skin cancer	0.000532	0.0064	CbGeAlD
Theophylline—CYP1A1—skin of body—skin cancer	0.000528	0.00635	CbGeAlD
Theophylline—Decreased appetite—Imiquimod—skin cancer	0.000524	0.00524	CcSEcCtD
Theophylline—Flushing—Dactinomycin—skin cancer	0.000522	0.00522	CcSEcCtD
Theophylline—Hypersensitivity—Vemurafenib—skin cancer	0.000521	0.00521	CcSEcCtD
Theophylline—Atrial fibrillation—Docetaxel—skin cancer	0.000516	0.00516	CcSEcCtD
Theophylline—Pruritus—Vemurafenib—skin cancer	0.0005	0.005	CcSEcCtD
Theophylline—Alopecia—Dactinomycin—skin cancer	0.000497	0.00497	CcSEcCtD
Theophylline—Gastrointestinal pain—Imiquimod—skin cancer	0.000493	0.00493	CcSEcCtD
Theophylline—CYP1B1—head—skin cancer	0.000487	0.00586	CbGeAlD
Theophylline—Diarrhoea—Vemurafenib—skin cancer	0.000483	0.00484	CcSEcCtD
Theophylline—CYP1A1—mammalian vulva—skin cancer	0.000482	0.00579	CbGeAlD
Theophylline—Urticaria—Imiquimod—skin cancer	0.000479	0.00479	CcSEcCtD
Theophylline—Abdominal pain—Imiquimod—skin cancer	0.000476	0.00477	CcSEcCtD
Theophylline—Body temperature increased—Imiquimod—skin cancer	0.000476	0.00477	CcSEcCtD
Theophylline—Flushing—Temozolomide—skin cancer	0.000472	0.00472	CcSEcCtD
Theophylline—Dizziness—Vemurafenib—skin cancer	0.000467	0.00467	CcSEcCtD
Theophylline—Vomiting—Vemurafenib—skin cancer	0.000449	0.00449	CcSEcCtD
Theophylline—Alopecia—Temozolomide—skin cancer	0.000449	0.00449	CcSEcCtD
Theophylline—CYP2C8—female reproductive system—skin cancer	0.000447	0.00538	CbGeAlD
Theophylline—Abdominal pain upper—Docetaxel—skin cancer	0.000446	0.00446	CcSEcCtD
Theophylline—Rash—Vemurafenib—skin cancer	0.000446	0.00446	CcSEcCtD
Theophylline—Dermatitis—Vemurafenib—skin cancer	0.000445	0.00445	CcSEcCtD
Theophylline—Hypersensitivity—Imiquimod—skin cancer	0.000444	0.00444	CcSEcCtD
Theophylline—Headache—Vemurafenib—skin cancer	0.000443	0.00443	CcSEcCtD
Theophylline—Anaphylactic shock—Bleomycin—skin cancer	0.000428	0.00428	CcSEcCtD
Theophylline—Pruritus—Imiquimod—skin cancer	0.000426	0.00427	CcSEcCtD
Theophylline—Infection—Bleomycin—skin cancer	0.000425	0.00426	CcSEcCtD
Theophylline—Nausea—Vemurafenib—skin cancer	0.00042	0.0042	CcSEcCtD
Theophylline—Arrhythmia—Fluorouracil—skin cancer	0.000418	0.00419	CcSEcCtD
Theophylline—Tremor—Temozolomide—skin cancer	0.000415	0.00415	CcSEcCtD
Theophylline—Alopecia—Fluorouracil—skin cancer	0.000414	0.00414	CcSEcCtD
Theophylline—CYP1A1—female reproductive system—skin cancer	0.000412	0.00496	CbGeAlD
Theophylline—Diarrhoea—Imiquimod—skin cancer	0.000412	0.00413	CcSEcCtD
Theophylline—Anorexia—Bleomycin—skin cancer	0.000408	0.00408	CcSEcCtD
Theophylline—Agitation—Temozolomide—skin cancer	0.000407	0.00407	CcSEcCtD
Theophylline—Hypotension—Bleomycin—skin cancer	0.0004	0.004	CcSEcCtD
Theophylline—Dizziness—Imiquimod—skin cancer	0.000398	0.00399	CcSEcCtD
Theophylline—PDE4B—lymph node—skin cancer	0.000398	0.00479	CbGeAlD
Theophylline—CYP2C9—female reproductive system—skin cancer	0.000397	0.00478	CbGeAlD
Theophylline—Infection—Dactinomycin—skin cancer	0.000397	0.00397	CcSEcCtD
Theophylline—Palpitations—Temozolomide—skin cancer	0.000391	0.00391	CcSEcCtD
Theophylline—CYP2E1—lymphoid tissue—skin cancer	0.00039	0.00469	CbGeAlD
Theophylline—Convulsion—Temozolomide—skin cancer	0.000383	0.00384	CcSEcCtD
Theophylline—Vomiting—Imiquimod—skin cancer	0.000383	0.00383	CcSEcCtD
Theophylline—Anorexia—Dactinomycin—skin cancer	0.000381	0.00381	CcSEcCtD
Theophylline—Rash—Imiquimod—skin cancer	0.00038	0.0038	CcSEcCtD
Theophylline—Dermatitis—Imiquimod—skin cancer	0.00038	0.0038	CcSEcCtD
Theophylline—Headache—Imiquimod—skin cancer	0.000378	0.00378	CcSEcCtD
Theophylline—CYP2E1—female reproductive system—skin cancer	0.000376	0.00453	CbGeAlD
Theophylline—Anxiety—Temozolomide—skin cancer	0.000375	0.00376	CcSEcCtD
Theophylline—Decreased appetite—Bleomycin—skin cancer	0.000372	0.00372	CcSEcCtD
Theophylline—Anaphylactic shock—Temozolomide—skin cancer	0.000361	0.00361	CcSEcCtD
Theophylline—Infection—Temozolomide—skin cancer	0.000359	0.00359	CcSEcCtD
Theophylline—Nausea—Imiquimod—skin cancer	0.000358	0.00358	CcSEcCtD
Theophylline—Nervous system disorder—Temozolomide—skin cancer	0.000354	0.00354	CcSEcCtD
Theophylline—Convulsion—Fluorouracil—skin cancer	0.000353	0.00353	CcSEcCtD
Theophylline—Decreased appetite—Dactinomycin—skin cancer	0.000347	0.00347	CcSEcCtD
Theophylline—CYP1A1—head—skin cancer	0.000345	0.00415	CbGeAlD
Theophylline—Anorexia—Temozolomide—skin cancer	0.000344	0.00344	CcSEcCtD
Theophylline—CYP1B1—lymph node—skin cancer	0.000341	0.00411	CbGeAlD
Theophylline—Urticaria—Bleomycin—skin cancer	0.00034	0.0034	CcSEcCtD
Theophylline—Body temperature increased—Bleomycin—skin cancer	0.000338	0.00339	CcSEcCtD
Theophylline—Anaphylactic shock—Fluorouracil—skin cancer	0.000333	0.00333	CcSEcCtD
Theophylline—Infection—Fluorouracil—skin cancer	0.000331	0.00331	CcSEcCtD
Theophylline—Insomnia—Temozolomide—skin cancer	0.000327	0.00327	CcSEcCtD
Theophylline—Gastrointestinal pain—Dactinomycin—skin cancer	0.000326	0.00327	CcSEcCtD
Theophylline—Nervous system disorder—Fluorouracil—skin cancer	0.000326	0.00326	CcSEcCtD
Theophylline—Tachycardia—Fluorouracil—skin cancer	0.000325	0.00325	CcSEcCtD
Theophylline—Anorexia—Fluorouracil—skin cancer	0.000317	0.00317	CcSEcCtD
Theophylline—Abdominal pain—Dactinomycin—skin cancer	0.000316	0.00316	CcSEcCtD
Theophylline—Body temperature increased—Dactinomycin—skin cancer	0.000316	0.00316	CcSEcCtD
Theophylline—Hypersensitivity—Bleomycin—skin cancer	0.000315	0.00316	CcSEcCtD
Theophylline—CYP2E1—head—skin cancer	0.000314	0.00378	CbGeAlD
Theophylline—Decreased appetite—Temozolomide—skin cancer	0.000314	0.00314	CcSEcCtD
Theophylline—Flushing—Docetaxel—skin cancer	0.000314	0.00314	CcSEcCtD
Theophylline—Hypotension—Fluorouracil—skin cancer	0.000311	0.00311	CcSEcCtD
Theophylline—Pruritus—Bleomycin—skin cancer	0.000303	0.00303	CcSEcCtD
Theophylline—CYP3A4—female reproductive system—skin cancer	0.000303	0.00364	CbGeAlD
Theophylline—Arrhythmia—Docetaxel—skin cancer	0.000302	0.00302	CcSEcCtD
Theophylline—Insomnia—Fluorouracil—skin cancer	0.000301	0.00301	CcSEcCtD
Theophylline—Alopecia—Docetaxel—skin cancer	0.000299	0.00299	CcSEcCtD
Theophylline—CYP2D6—female reproductive system—skin cancer	0.000298	0.00358	CbGeAlD
Theophylline—Gastrointestinal pain—Temozolomide—skin cancer	0.000295	0.00295	CcSEcCtD
Theophylline—Hypersensitivity—Dactinomycin—skin cancer	0.000294	0.00294	CcSEcCtD
Theophylline—Decreased appetite—Fluorouracil—skin cancer	0.000289	0.00289	CcSEcCtD
Theophylline—Urticaria—Temozolomide—skin cancer	0.000287	0.00287	CcSEcCtD
Theophylline—Abdominal pain—Temozolomide—skin cancer	0.000285	0.00286	CcSEcCtD
Theophylline—Body temperature increased—Temozolomide—skin cancer	0.000285	0.00286	CcSEcCtD
Theophylline—Diarrhoea—Dactinomycin—skin cancer	0.000273	0.00273	CcSEcCtD
Theophylline—Vomiting—Bleomycin—skin cancer	0.000272	0.00272	CcSEcCtD
Theophylline—Rash—Bleomycin—skin cancer	0.00027	0.0027	CcSEcCtD
Theophylline—Dermatitis—Bleomycin—skin cancer	0.00027	0.0027	CcSEcCtD
Theophylline—Hypersensitivity—Temozolomide—skin cancer	0.000266	0.00266	CcSEcCtD
Theophylline—Urticaria—Fluorouracil—skin cancer	0.000264	0.00264	CcSEcCtD
Theophylline—Body temperature increased—Fluorouracil—skin cancer	0.000263	0.00263	CcSEcCtD
Theophylline—Palpitations—Docetaxel—skin cancer	0.00026	0.0026	CcSEcCtD
Theophylline—Pruritus—Temozolomide—skin cancer	0.000255	0.00256	CcSEcCtD
Theophylline—Convulsion—Docetaxel—skin cancer	0.000255	0.00255	CcSEcCtD
Theophylline—Nausea—Bleomycin—skin cancer	0.000254	0.00254	CcSEcCtD
Theophylline—Vomiting—Dactinomycin—skin cancer	0.000254	0.00254	CcSEcCtD
Theophylline—Rash—Dactinomycin—skin cancer	0.000252	0.00252	CcSEcCtD
Theophylline—CYP2D6—head—skin cancer	0.000249	0.00299	CbGeAlD
Theophylline—Diarrhoea—Temozolomide—skin cancer	0.000247	0.00247	CcSEcCtD
Theophylline—Hypersensitivity—Fluorouracil—skin cancer	0.000245	0.00245	CcSEcCtD
Theophylline—CYP1A1—lymph node—skin cancer	0.000241	0.0029	CbGeAlD
Theophylline—Anaphylactic shock—Docetaxel—skin cancer	0.00024	0.0024	CcSEcCtD
Theophylline—Dizziness—Temozolomide—skin cancer	0.000239	0.00239	CcSEcCtD
Theophylline—Infection—Docetaxel—skin cancer	0.000239	0.00239	CcSEcCtD
Theophylline—Nausea—Dactinomycin—skin cancer	0.000237	0.00237	CcSEcCtD
Theophylline—Shock—Docetaxel—skin cancer	0.000236	0.00236	CcSEcCtD
Theophylline—Nervous system disorder—Docetaxel—skin cancer	0.000236	0.00236	CcSEcCtD
Theophylline—Pruritus—Fluorouracil—skin cancer	0.000235	0.00236	CcSEcCtD
Theophylline—Tachycardia—Docetaxel—skin cancer	0.000234	0.00234	CcSEcCtD
Theophylline—Vomiting—Temozolomide—skin cancer	0.00023	0.0023	CcSEcCtD
Theophylline—Anorexia—Docetaxel—skin cancer	0.000229	0.00229	CcSEcCtD
Theophylline—Rash—Temozolomide—skin cancer	0.000228	0.00228	CcSEcCtD
Theophylline—Diarrhoea—Fluorouracil—skin cancer	0.000228	0.00228	CcSEcCtD
Theophylline—Dermatitis—Temozolomide—skin cancer	0.000227	0.00228	CcSEcCtD
Theophylline—Headache—Temozolomide—skin cancer	0.000226	0.00226	CcSEcCtD
Theophylline—Hypotension—Docetaxel—skin cancer	0.000224	0.00225	CcSEcCtD
Theophylline—Dizziness—Fluorouracil—skin cancer	0.00022	0.0022	CcSEcCtD
Theophylline—Insomnia—Docetaxel—skin cancer	0.000217	0.00217	CcSEcCtD
Theophylline—Nausea—Temozolomide—skin cancer	0.000214	0.00215	CcSEcCtD
Theophylline—Vomiting—Fluorouracil—skin cancer	0.000212	0.00212	CcSEcCtD
Theophylline—Rash—Fluorouracil—skin cancer	0.00021	0.0021	CcSEcCtD
Theophylline—Dermatitis—Fluorouracil—skin cancer	0.00021	0.0021	CcSEcCtD
Theophylline—Decreased appetite—Docetaxel—skin cancer	0.000209	0.00209	CcSEcCtD
Theophylline—Headache—Fluorouracil—skin cancer	0.000208	0.00209	CcSEcCtD
Theophylline—Nausea—Fluorouracil—skin cancer	0.000198	0.00198	CcSEcCtD
Theophylline—Gastrointestinal pain—Docetaxel—skin cancer	0.000196	0.00196	CcSEcCtD
Theophylline—Abdominal pain—Docetaxel—skin cancer	0.00019	0.0019	CcSEcCtD
Theophylline—Body temperature increased—Docetaxel—skin cancer	0.00019	0.0019	CcSEcCtD
Theophylline—Hypersensitivity—Docetaxel—skin cancer	0.000177	0.00177	CcSEcCtD
Theophylline—Pruritus—Docetaxel—skin cancer	0.00017	0.0017	CcSEcCtD
Theophylline—Diarrhoea—Docetaxel—skin cancer	0.000164	0.00164	CcSEcCtD
Theophylline—Dizziness—Docetaxel—skin cancer	0.000159	0.00159	CcSEcCtD
Theophylline—Vomiting—Docetaxel—skin cancer	0.000153	0.00153	CcSEcCtD
Theophylline—Rash—Docetaxel—skin cancer	0.000151	0.00151	CcSEcCtD
Theophylline—Dermatitis—Docetaxel—skin cancer	0.000151	0.00151	CcSEcCtD
Theophylline—Headache—Docetaxel—skin cancer	0.00015	0.00151	CcSEcCtD
Theophylline—Nausea—Docetaxel—skin cancer	0.000143	0.00143	CcSEcCtD
Theophylline—PDE3B—Signaling Pathways—RASA1—skin cancer	5.52e-05	0.000706	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—SHH—skin cancer	5.47e-05	0.000698	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—PTCH1—skin cancer	5.43e-05	0.000694	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—SMO—skin cancer	5.43e-05	0.000694	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—RASA1—skin cancer	5.43e-05	0.000694	CbGpPWpGaD
Theophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	5.31e-05	0.000679	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—SUFU—skin cancer	5.31e-05	0.000678	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—PTGER4—skin cancer	5.29e-05	0.000676	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MC1R—skin cancer	5.28e-05	0.000675	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—PTCH1—skin cancer	5.27e-05	0.000673	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—SMO—skin cancer	5.27e-05	0.000673	CbGpPWpGaD
Theophylline—PDE5A—Hemostasis—TP53—skin cancer	5.25e-05	0.000671	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—SHH—skin cancer	5.2e-05	0.000665	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—GLI1—skin cancer	5.2e-05	0.000665	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—PTCH1—skin cancer	5.18e-05	0.000662	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—SMO—skin cancer	5.18e-05	0.000662	CbGpPWpGaD
Theophylline—HDAC2—Circadian rythm related genes—TP53—skin cancer	5.18e-05	0.000662	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—RASA1—skin cancer	5.17e-05	0.000661	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—PTGER4—skin cancer	5.13e-05	0.000655	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—FOXO4—skin cancer	5.12e-05	0.000654	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	5.12e-05	0.000654	CbGpPWpGaD
Theophylline—HDAC2—Signaling by NGF—NRAS—skin cancer	5.11e-05	0.000652	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—SHH—skin cancer	5.06e-05	0.000647	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—PTGER4—skin cancer	5.04e-05	0.000645	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—RASA1—skin cancer	5.03e-05	0.000643	CbGpPWpGaD
Theophylline—PDE5A—Hemostasis—HRAS—skin cancer	5.02e-05	0.000642	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—SUFU—skin cancer	4.93e-05	0.00063	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—SMO—skin cancer	4.93e-05	0.00063	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PTCH1—skin cancer	4.93e-05	0.00063	CbGpPWpGaD
Theophylline—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	4.89e-05	0.000625	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—SHH—skin cancer	4.87e-05	0.000623	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—RASA1—skin cancer	4.84e-05	0.000619	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—SHH—skin cancer	4.81e-05	0.000615	CbGpPWpGaD
Theophylline—ADORA2A—Circadian rythm related genes—TP53—skin cancer	4.81e-05	0.000615	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PTGER4—skin cancer	4.8e-05	0.000614	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—SMO—skin cancer	4.8e-05	0.000613	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PTCH1—skin cancer	4.8e-05	0.000613	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—RASA1—skin cancer	4.78e-05	0.000611	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by NGF—NRAS—skin cancer	4.75e-05	0.000606	CbGpPWpGaD
Theophylline—HDAC2—Circadian rythm related genes—IL6—skin cancer	4.74e-05	0.000606	CbGpPWpGaD
Theophylline—HDAC2—Disease—FOXO4—skin cancer	4.71e-05	0.000602	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—CSPG4—skin cancer	4.68e-05	0.000598	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—FOXO4—skin cancer	4.67e-05	0.000597	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PTGER4—skin cancer	4.67e-05	0.000597	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PTCH1—skin cancer	4.62e-05	0.00059	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—SMO—skin cancer	4.62e-05	0.00059	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—SMO—skin cancer	4.56e-05	0.000583	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PTCH1—skin cancer	4.56e-05	0.000583	CbGpPWpGaD
Theophylline—ADA—Metabolism—ERCC2—skin cancer	4.55e-05	0.000581	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—FOXO4—skin cancer	4.53e-05	0.000579	CbGpPWpGaD
Theophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	4.51e-05	0.000577	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PTGER4—skin cancer	4.5e-05	0.000574	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—FOXO4—skin cancer	4.46e-05	0.000569	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PTGER4—skin cancer	4.44e-05	0.000568	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—NRAS—skin cancer	4.44e-05	0.000568	CbGpPWpGaD
Theophylline—ADORA2A—Circadian rythm related genes—IL6—skin cancer	4.41e-05	0.000563	CbGpPWpGaD
Theophylline—HDAC2—Signaling by NGF—KRAS—skin cancer	4.39e-05	0.000561	CbGpPWpGaD
Theophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	4.32e-05	0.000552	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—FOXO4—skin cancer	4.24e-05	0.000542	CbGpPWpGaD
Theophylline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	4.16e-05	0.000531	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—FOXO4—skin cancer	4.13e-05	0.000527	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by NGF—KRAS—skin cancer	4.09e-05	0.000522	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—SHH—skin cancer	4.05e-05	0.000517	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—NRAS—skin cancer	4.05e-05	0.000517	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—RASA1—skin cancer	4.02e-05	0.000514	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—FOXO4—skin cancer	3.97e-05	0.000507	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—FOXO4—skin cancer	3.92e-05	0.000501	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PTCH1—skin cancer	3.84e-05	0.00049	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—SMO—skin cancer	3.84e-05	0.00049	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—KRAS—skin cancer	3.82e-05	0.000488	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PLIN2—skin cancer	3.79e-05	0.000484	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—SHH—skin cancer	3.76e-05	0.000481	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—RASA1—skin cancer	3.74e-05	0.000478	CbGpPWpGaD
Theophylline—HDAC2—Signaling by NGF—HRAS—skin cancer	3.74e-05	0.000477	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PTGER4—skin cancer	3.73e-05	0.000477	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—ERCC2—skin cancer	3.62e-05	0.000462	CbGpPWpGaD
Theophylline—HDAC2—Signaling by NGF—IL6—skin cancer	3.57e-05	0.000457	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PLIN2—skin cancer	3.57e-05	0.000457	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—SMO—skin cancer	3.57e-05	0.000456	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PTCH1—skin cancer	3.57e-05	0.000456	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—KRAS—skin cancer	3.48e-05	0.000445	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by NGF—HRAS—skin cancer	3.47e-05	0.000444	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PTGER4—skin cancer	3.47e-05	0.000444	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TERT—skin cancer	3.42e-05	0.000437	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—TP53—skin cancer	3.4e-05	0.000434	CbGpPWpGaD
Theophylline—HDAC2—Disease—ERCC2—skin cancer	3.36e-05	0.000429	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by NGF—IL6—skin cancer	3.32e-05	0.000425	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—FOXO4—skin cancer	3.3e-05	0.000421	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PLIN2—skin cancer	3.28e-05	0.000419	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—HRAS—skin cancer	3.25e-05	0.000415	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—NRAS—skin cancer	3.23e-05	0.000413	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—ENO2—skin cancer	3.18e-05	0.000406	CbGpPWpGaD
Theophylline—HDAC2—Disease—TERT—skin cancer	3.15e-05	0.000402	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TERT—skin cancer	3.12e-05	0.000399	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—TP53—skin cancer	3.1e-05	0.000395	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—FOXO4—skin cancer	3.07e-05	0.000392	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—CSPG4—skin cancer	3.06e-05	0.00039	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TERT—skin cancer	3.03e-05	0.000387	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TERT—skin cancer	2.98e-05	0.00038	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—HRAS—skin cancer	2.96e-05	0.000378	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—CSPG4—skin cancer	2.88e-05	0.000368	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—NRAS—skin cancer	2.88e-05	0.000368	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TERT—skin cancer	2.83e-05	0.000362	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—KRAS—skin cancer	2.78e-05	0.000356	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TERT—skin cancer	2.76e-05	0.000352	CbGpPWpGaD
Theophylline—ADA—Metabolism—PTGS2—skin cancer	2.73e-05	0.000349	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—BRAF—skin cancer	2.71e-05	0.000346	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PLIN2—skin cancer	2.69e-05	0.000344	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PLIN2—skin cancer	2.67e-05	0.000341	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TERT—skin cancer	2.65e-05	0.000339	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CSPG4—skin cancer	2.64e-05	0.000337	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—NRAS—skin cancer	2.63e-05	0.000336	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TERT—skin cancer	2.62e-05	0.000335	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—NRAS—skin cancer	2.55e-05	0.000326	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—NRAS—skin cancer	2.51e-05	0.00032	CbGpPWpGaD
Theophylline—HDAC2—Disease—BRAF—skin cancer	2.49e-05	0.000318	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.49e-05	0.000318	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—KRAS—skin cancer	2.48e-05	0.000317	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—TP53—skin cancer	2.47e-05	0.000316	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—BRAF—skin cancer	2.47e-05	0.000316	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—BRAF—skin cancer	2.4e-05	0.000306	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—NRAS—skin cancer	2.39e-05	0.000305	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—HRAS—skin cancer	2.37e-05	0.000302	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—BRAF—skin cancer	2.36e-05	0.000301	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—NRAS—skin cancer	2.32e-05	0.000297	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PLIN2—skin cancer	2.28e-05	0.000291	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—KRAS—skin cancer	2.26e-05	0.000289	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—BRAF—skin cancer	2.24e-05	0.000287	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—NRAS—skin cancer	2.24e-05	0.000286	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—NRAS—skin cancer	2.21e-05	0.000282	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TERT—skin cancer	2.2e-05	0.000281	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—KRAS—skin cancer	2.19e-05	0.00028	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—BRAF—skin cancer	2.18e-05	0.000279	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CSPG4—skin cancer	2.17e-05	0.000277	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—KRAS—skin cancer	2.16e-05	0.000276	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CSPG4—skin cancer	2.15e-05	0.000275	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—HRAS—skin cancer	2.11e-05	0.000269	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—BRAF—skin cancer	2.1e-05	0.000268	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ENO2—skin cancer	2.08e-05	0.000265	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—BRAF—skin cancer	2.08e-05	0.000265	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—KRAS—skin cancer	2.05e-05	0.000262	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TERT—skin cancer	2.05e-05	0.000262	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—IL6—skin cancer	2.02e-05	0.000258	CbGpPWpGaD
Theophylline—HDAC2—Disease—PTGS2—skin cancer	2.01e-05	0.000257	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—KRAS—skin cancer	2e-05	0.000255	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ENO2—skin cancer	1.96e-05	0.00025	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—KRAS—skin cancer	1.92e-05	0.000246	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—HRAS—skin cancer	1.92e-05	0.000246	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—KRAS—skin cancer	1.9e-05	0.000243	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—HRAS—skin cancer	1.87e-05	0.000238	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—ERCC2—skin cancer	1.85e-05	0.000236	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—IL6—skin cancer	1.84e-05	0.000235	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CSPG4—skin cancer	1.84e-05	0.000235	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—HRAS—skin cancer	1.83e-05	0.000234	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ENO2—skin cancer	1.8e-05	0.000229	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—IL6—skin cancer	1.79e-05	0.000228	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PLIN2—skin cancer	1.76e-05	0.000225	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—IL6—skin cancer	1.76e-05	0.000224	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—HRAS—skin cancer	1.75e-05	0.000223	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—BRAF—skin cancer	1.74e-05	0.000223	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—NRAS—skin cancer	1.73e-05	0.00022	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—NRAS—skin cancer	1.7e-05	0.000217	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—HRAS—skin cancer	1.7e-05	0.000217	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—IL6—skin cancer	1.67e-05	0.000214	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—HRAS—skin cancer	1.64e-05	0.000209	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—IL6—skin cancer	1.63e-05	0.000208	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—BRAF—skin cancer	1.62e-05	0.000207	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—HRAS—skin cancer	1.62e-05	0.000206	CbGpPWpGaD
Theophylline—HDAC2—Disease—NRAS—skin cancer	1.57e-05	0.0002	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—IL6—skin cancer	1.57e-05	0.0002	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—NRAS—skin cancer	1.55e-05	0.000198	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—IL6—skin cancer	1.55e-05	0.000198	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.53e-05	0.000196	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—NRAS—skin cancer	1.51e-05	0.000192	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—KRAS—skin cancer	1.49e-05	0.00019	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—NRAS—skin cancer	1.48e-05	0.000189	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ENO2—skin cancer	1.47e-05	0.000188	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—KRAS—skin cancer	1.46e-05	0.000187	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ENO2—skin cancer	1.46e-05	0.000187	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CSPG4—skin cancer	1.42e-05	0.000181	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—NRAS—skin cancer	1.41e-05	0.00018	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.4e-05	0.000179	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—NRAS—skin cancer	1.37e-05	0.000175	CbGpPWpGaD
Theophylline—HDAC2—Disease—KRAS—skin cancer	1.35e-05	0.000172	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—KRAS—skin cancer	1.34e-05	0.000171	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—NRAS—skin cancer	1.32e-05	0.000169	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—NRAS—skin cancer	1.3e-05	0.000167	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TP53—skin cancer	1.3e-05	0.000166	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—KRAS—skin cancer	1.3e-05	0.000166	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—KRAS—skin cancer	1.27e-05	0.000163	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—HRAS—skin cancer	1.26e-05	0.000161	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ENO2—skin cancer	1.25e-05	0.00016	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—HRAS—skin cancer	1.24e-05	0.000159	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—KRAS—skin cancer	1.21e-05	0.000155	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—IL6—skin cancer	1.21e-05	0.000154	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ERCC2—skin cancer	1.21e-05	0.000154	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IL6—skin cancer	1.19e-05	0.000152	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TP53—skin cancer	1.19e-05	0.000152	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—KRAS—skin cancer	1.18e-05	0.000151	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TP53—skin cancer	1.15e-05	0.000147	CbGpPWpGaD
Theophylline—HDAC2—Disease—HRAS—skin cancer	1.15e-05	0.000146	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.14e-05	0.000146	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ERCC2—skin cancer	1.14e-05	0.000145	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—KRAS—skin cancer	1.14e-05	0.000145	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—HRAS—skin cancer	1.14e-05	0.000145	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TP53—skin cancer	1.13e-05	0.000145	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—KRAS—skin cancer	1.12e-05	0.000143	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTGS2—skin cancer	1.11e-05	0.000142	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—HRAS—skin cancer	1.1e-05	0.000141	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—NRAS—skin cancer	1.1e-05	0.00014	CbGpPWpGaD
Theophylline—HDAC2—Disease—IL6—skin cancer	1.1e-05	0.00014	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL6—skin cancer	1.09e-05	0.000139	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—HRAS—skin cancer	1.08e-05	0.000138	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TP53—skin cancer	1.08e-05	0.000138	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL6—skin cancer	1.05e-05	0.000135	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TP53—skin cancer	1.05e-05	0.000134	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ERCC2—skin cancer	1.04e-05	0.000133	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL6—skin cancer	1.04e-05	0.000133	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—HRAS—skin cancer	1.03e-05	0.000132	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—NRAS—skin cancer	1.02e-05	0.00013	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TP53—skin cancer	1.01e-05	0.000129	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—HRAS—skin cancer	1e-05	0.000128	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TP53—skin cancer	9.98e-06	0.000128	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL6—skin cancer	9.87e-06	0.000126	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	9.77e-06	0.000125	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—HRAS—skin cancer	9.66e-06	0.000123	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ENO2—skin cancer	9.64e-06	0.000123	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL6—skin cancer	9.6e-06	0.000123	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—HRAS—skin cancer	9.54e-06	0.000122	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KRAS—skin cancer	9.44e-06	0.000121	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL6—skin cancer	9.25e-06	0.000118	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL6—skin cancer	9.14e-06	0.000117	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KRAS—skin cancer	8.77e-06	0.000112	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ERCC2—skin cancer	8.56e-06	0.000109	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ERCC2—skin cancer	8.49e-06	0.000108	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TP53—skin cancer	8.39e-06	0.000107	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—HRAS—skin cancer	8.02e-06	0.000102	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TP53—skin cancer	7.8e-06	9.96e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL6—skin cancer	7.68e-06	9.81e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—HRAS—skin cancer	7.46e-06	9.53e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ERCC2—skin cancer	7.25e-06	9.27e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTGS2—skin cancer	7.23e-06	9.24e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL6—skin cancer	7.14e-06	9.12e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTGS2—skin cancer	6.82e-06	8.71e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTGS2—skin cancer	6.25e-06	7.99e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ERCC2—skin cancer	5.6e-06	7.15e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTGS2—skin cancer	5.13e-06	6.56e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTGS2—skin cancer	5.09e-06	6.5e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTGS2—skin cancer	4.35e-06	5.56e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTGS2—skin cancer	3.36e-06	4.29e-05	CbGpPWpGaD
